Clinical trial NCT03998072: Does Five Session CAT Consultancy Lead to Improved Outcomes?
Official title: Does Five Session CAT (Cognitive Analytic Therapy) Consultancy Lead to Improve Outcomes for Patients and Care Coordinators?
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Psychological Intervention
Treatment as Usual
Keywords: psychology
cognitive analytic therapy
Lead sponsor: University of Sheffield
Sponsor class: OTHER
Collaborators: name: National Health Service, United Kingdom
First posted: 2019-06-25
Enrollment: 24
Sex: ALL
Minimum age (years): 18
Maximum age (years): 100
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: CROSSOVER
Intervention model description: The study will utilise two conditions - intervention and waiting list. Participants on the waiting list will then proceed to the intervention condition.
Primary purpose: TREATMENT

Brief summary: Five session CAT (Cognitive Analytic Therapy) consultancy was developed for patients whom services 'struggle to help', such as those with diagnoses of personality disorder. Five session CAT consultancy works with both patients and care coordinators, utilising key elements of CAT including reciprocal roles and reformulation to inform care planning and case management. The proposed study expands on the existing evidence base by utilising a comparator; a treatment as usual condition. The proposed mixed methods feasibility study will compare outcomes for both patients and care coordinators to assess the effectiveness of the intervention compared to controls in a community mental health team.


Eligibility criteria: Inclusion Criteria:

1. they are indicated as unsuitable for individual therapy,
2. there is a poor or challenging relationship between the patient and the care coordinator(s)
3. the care coordinator(s) feels a sense of 'stuckness' with the case
4. the patient is chaotic

Exclusion Criteria:

1. actively psychotic
2. severely misusing substances
3. have poor appointment attendance
4. indicating that they are actively suicidal and unwilling to commit to trying to stay safe.

Primary outcomes:
measure: Personality Structure Questionnaire (PSQ)
timeFrame: Screening (point of referral), start of waiting list (up to 2 weeks), end of waiting list (up to 12 weeks), start of treatment (up to 12 weeks), end of treatment (up to 22 weeks), 8 week follow-up (up to 30 weeks), 12 week follow-up (up to 34 weeks)
measure: Perceived competence scale
timeFrame: Screening (point of referral), start of waiting list (up to 2 weeks), end of waiting list (up to 12 weeks), start of treatment (up to 12 weeks), end of treatment (up to 22 weeks), 8 week follow-up (up to 30 weeks), 12 week follow-up (up to 34 weeks)
Secondary outcomes:
measure: Clinical Outcomes in Routine Evaluation (CORE-10)
timeFrame: Screening (point of referral), start of waiting list (up to 2 weeks), end of waiting list (up to 12 weeks), start of treatment (up to 12 weeks), end of treatment (up to 22 weeks), 8 week follow-up (up to 30 weeks), 12 week follow-up (up to 34 weeks)
measure: Working Alliance Inventory Short-Revised (WAI-SR)
timeFrame: Screening (point of referral), start of waiting list (up to 2 weeks), end of waiting list (up to 12 weeks), start of treatment (up to 12 weeks), end of treatment (up to 22 weeks), 8 week follow-up (up to 30 weeks), 12 week follow-up (up to 34 weeks)
measure: Doubt Subscale of the Mental Health Professionals Stress Scale (MHPSS)
timeFrame: Screening (point of referral), start of waiting list (up to 2 weeks), end of waiting list (up to 12 weeks), start of treatment (up to 12 weeks), end of treatment (up to 22 weeks), 8 week follow-up (up to 30 weeks), 12 week follow-up (up to 34 weeks)
Other outcomes:
Locations:
city: Rotherham
country: United Kingdom
facility: Rotherham Doncaster and South Humber NHS Foundation Trust
Study officials:
References: